Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Nonhaematologic Malignancies
Interventions: DRUG: BOS172722|DRUG: Paclitaxel
Sponsor: Boston Pharmaceuticals